SearchDictionaryMobileLogin

Temazepam (Nocturne)

297  relevant articles (12 outcomes, 43 trials/studies) found for this Drug

Description: A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent.

Also Known As:
Nocturne; Planum; Restoril; Normison; 3-Hydroxydiazepam; AHP Brand of Temazepam; Alphapharm Brand of Temazepam; Apo-Temazepam; Apotex Brand of Temazepam; Dasuen; Desitin Brand of Temazepam; Euhypnos; Gen-Temazepam; Genopharm Brand of Temazepam; Genpharm Brand of Temazepam; ICN Brand of Temazepam; Katwijk Brand of Temazepam; Knoll Brand of Temazepam; Levanxol; Mallinckrodt Brand of Temazepam; Normitab; Nortem; Norton Brand of Temazepam; Novartis Brand of Temazepam; Novo-Temazepam; Novopharm Brand of Temazepam; Nu-Pharm Brand of Temazepam; Nu-Temazepam; Orion Brand of Temazepam; Oxydiazepam; PMS-Temazepam; Pharmacia Brand of Temazepam; Pharmascience Brand of Temazepam; Pronervon T; Remestan; Ro-5-5345; SaH 47-603; Scheffler Brand of Temazepam; Sigma Brand of Temazepam; Signopam; Temaze; Temtabs; Tenox; WY-3917; Wyeth Brand of Temazepam; ct-Arzneimittel Brand of Temazepam; temazep von ct; 3 Hydroxydiazepam; Apo Temazepam; Gen Temazepam; Novo Temazepam; Nu Pharm Brand of Temazepam; Nu Temazepam; PMS Temazepam; Ro 5 5345; Ro55345; SaH 47 603; SaH 47603; Tema, Norkotral; WY 3917; WY3917; ct Arzneimittel Brand of Temazepam; Hydroxydiazepam; Methyloxazepam; Norkotral Tema; 2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-

Relationship Network

Drug Context: Research Results

Experts

1. Kasai, Kiyoto: 3 articles (09/2007 - 08/2003)
2. Abe, Osamu: 2 articles (09/2007 - 06/2004)
3. Iwanami, Akira: 2 articles (09/2007 - 06/2004)
4. Hirayasu, Yoshio: 2 articles (09/2007 - 08/2003)
5. Aoki, Shigeki: 2 articles (09/2007 - 06/2004)
6. Yamada, Haruyasu: 2 articles (09/2007 - 06/2004)
7. Yamasue, Hidenori: 2 articles (09/2007 - 06/2004)
8. Kato, Nobumasa: 2 articles (09/2007 - 06/2004)
9. Rogers, Sally J: 2 articles (08/2005 - 08/2002)
10. Rojas, Donald C: 2 articles (08/2005 - 08/2002)

Related Diseases

1. Sleep Initiation and Maintenance Disorders (Insomnia)
2. Meningioma (Meningiomas)
3. Squamous Cell Carcinoma (Epidermoid Carcinoma)
4. Pain (Aches)
5. Infection

Related Drugs and Biologics

1. Triazolam (Halcion)
2. Diazepam (Valium)
3. Flurazepam (Dalmane)
4. Benzodiazepines
5. zolpidem (Ambien)
6. Hypnotics and Sedatives (Sedatives)
7. Nitrazepam (Serenade)
8. zopiclone (Zop)
9. Flunitrazepam (Rohypnol)
10. nefazodone (Serzone)

Related Therapies and Procedures

1. Photochemotherapy (Photodynamic Therapy)
2. Drug Therapy (Chemotherapy)
3. Craniotomy
4. Premedication
5. Electrodes (Electrode)

Best Treatments:
Research Summary Report
on Sleep Initiation and Maintenance Disorders

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 299 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>